Vertex Pharmaceuticals Incorporated shares owned by Meiji Yasuda Asset Management Company
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Meiji Yasuda Asset Management Company
from 13F filings
Historical chart of Meiji Yasuda Asset Management Company investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Meiji Yasuda Asset Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Meiji Yasuda Asset Management Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $2.9M | 8.3k | 347.74 |
2023-06-30 | $1.9M | 5.3k | 351.87 |
2023-03-31 | $1.7M | 5.3k | 315.15 |
2022-12-31 | $2.6M | 9.1k | 288.73 |
2022-09-30 | $5.8M | 20k | 289.54 |
2022-06-30 | $5.7M | 20k | 281.78 |
2022-03-31 | $5.8M | 22k | 260.96 |
2021-12-31 | $5.1M | 23k | 219.60 |
2021-09-30 | $4.2M | 23k | 181.38 |
2021-06-30 | $4.5M | 23k | 201.64 |
2021-03-31 | $4.9M | 23k | 214.90 |
2020-12-31 | $5.1M | 22k | 236.36 |
2020-09-30 | $4.3M | 16k | 272.12 |
2020-06-30 | $5.2M | 18k | 290.30 |
2020-03-31 | $1.1M | 4.8k | 237.85 |
2019-12-31 | $1.4M | 6.5k | 219.01 |
2019-09-30 | $1.5M | 9.0k | 169.41 |
2019-06-30 | $1.5M | 8.0k | 183.44 |
2019-03-31 | $1.3M | 7.2k | 184.01 |
2018-12-31 | $933k | 5.6k | 165.75 |
2018-09-30 | $1.1M | 5.7k | 192.69 |
2018-06-30 | $872k | 5.1k | 170.01 |
2018-03-31 | $1.1M | 6.5k | 163.01 |
2017-12-31 | $556k | 3.7k | 149.91 |
2017-09-30 | $564k | 3.7k | 152.06 |
2017-06-30 | $697k | 5.4k | 128.86 |
2017-03-31 | $351k | 3.2k | 109.38 |
2016-12-31 | $236k | 3.2k | 73.54 |
2016-09-30 | $280k | 3.2k | 87.25 |
2016-06-30 | $201k | 2.3k | 85.93 |
More positions owned by Meiji Yasuda Asset Management Company
View all positions for Meiji Yasuda Asset Management Company
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated